## MCHP: Microchip Technology Incorporat - XLK: Technology

### Executive Summary

No thesis match: MRS_10 0.4% below STRENGTH zone (3.0-6.0%); PEG 5.70 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-9.6% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($60.90)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_10 falling below -5% or breaking key support

### News

- **Articles:** 8
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Hershey Financial Advisers LLC Takes Position in Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251214T102542 | Neutral | Relevance: 100%
- Hershey Financial Advisers LLC has acquired a new stake in Microchip Technology Inc. (NASDAQ:MCHP), purchasing 24,029 shares valued at approximately $1.691 million, making it the firm's 24th largest holding. This comes as Microchip Technology exceeded Q2 earnings estimates with a negative net margin and a CFO stock sale, while analysts maintain a "Moderate Buy" consensus with a $74.95 price target. The company also announced a quarterly dividend of $0.455, despite a negative earnings-based payout ratio.

**2. Microchip Technology (MCHP): Reassessing Valuation After Raised Outlook and AI-Driven Data Center Demand**
- Source: Simply Wall Street | 20251214T030809 | Bullish | Relevance: 100%
- Microchip Technology (MCHP) recently raised its December quarter outlook, projecting about 1% sequential sales growth and 12% revenue growth year over year, driven by AI-related data center demand. While their valuation remains modestly discounted according to analyst targets, Simply Wall St's DCF model suggests the stock may be overvalued based on cash flows. The article explores whether the stock is still mispriced for recovery or already reflects future growth.

**3. Mizuho Adjusts Price Target on Microchip Technology to $80 From $75, Maintains Outperform Rating**
- Source: marketscreener.com | 20251216T144516 | Bullish | Relevance: 100%
- Mizuho has increased its price target for Microchip Technology (MCHP) to $80 from $75, while reiterating an Outperform rating. This adjustment follows Microchip Technology's recent upward revision of its fiscal Q3 guidance for both revenue and non-GAAP EPS. The company now expects Q3 revenue at the high end of its previous outlook ($1.11B-$1.15B) and non-GAAP EPS of $0.40.

**4. Coppell Advisory Solutions LLC Buys New Position in Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251215T092519 | Somewhat-Bullish | Relevance: 100%
- Coppell Advisory Solutions LLC recently acquired a new position in Microchip Technology (NASDAQ:MCHP), purchasing 15,128 shares valued at approximately $1.07 million during the second quarter. Despite a recent sale of 4,292 shares by CFO James Eric Bjornholt, analysts maintain a "Moderate Buy" rating with a consensus price target of $74.95. The company reported strong quarterly earnings, surpassing analyst estimates, and announced a quarterly dividend of $0.455 per share.

**5. LMR Partners LLP Invests $14.07 Million in Microchip Technology Incorporated $MCHP**
- Source: MarketBeat | 20251214T134914 | Neutral | Relevance: 100%
- LMR Partners LLP purchased a significant new stake in Microchip Technology Incorporated (NASDAQ:MCHP) during the second quarter, acquiring 200,000 shares valued at approximately $14.07 million. Other institutional investors also increased their holdings, contributing to approximately 91.51% institutional ownership of MCHP. Despite mixed analyst sentiment, the stock maintains a "Moderate Buy" rating with an average target price of $74.95.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-16 | Cantor Fitzgera | $85 | $65 | +31% |
| 2025-12-05 | B of A Securiti | $72 | $67 | +7% |
| 2025-12-04 | Needham | $75 | $73 | +3% |
| 2025-12-03 | Rosenblatt | $80 | $80 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-16 | Cantor Fitzgera | up | Overweight |
| 2025-12-05 | B of A Securiti | main | Neutral |
| 2025-12-04 | Needham | main | Buy |
| 2025-12-03 | Rosenblatt | main | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 16 ($0.27M) |
| Sells | 6 ($9.31M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 53.2% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 4 |

**Top Holders:**
- Vanguard Group Inc: 13.3% (+2.1%)
- Blackrock Inc.: 9.7% (-2.0%)
- Tudor Investment Cor: 9.5% (+100.0%)
- State Street Corpora: 5.2% (-11.9%)
- Boston Partners: 3.0% (+9.5%)

### Key Risks

1. Insider selling cluster: $9.3M in recent transactions.
2. Valuation stretched: PEG 5.7x requires aggressive growth execution.
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +14%) could attract flows.
- AI/machine learning initiatives could drive multiple expansion if executed.

### Fundamentals

PEG ratio 5.70 signals overvaluation risk, limited margin of safety. Forward P/E 26.4x attractive for 72% earnings growth. Balance sheet: strong liquidity (2.2x). Analyst sentiment positive (3 raises, avg +14%). Insider selling cluster ($9.3M in 90 days), potential headwind. Institutional flow bullish (6 buying vs 4 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $35.6B |
| Beta | 1.46 |
| 52W Range | $34.13 - $77.20 |
| Short Interest | 5.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 5.70 |
| Forward P/E | 26.4 |
| Current P/E | 45.3 |
| YoY Growth | 71.8% |
| EPS Direction | STABLE |

### Technicals

MRS_10 deteriorating from 10.0% to 0.4% (-9.6% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 2.6pp (needs >3.0% for momentum thesis). MRS_5 (-1.4%) diverging from MRS_10 - short-term weakness emerging. Full SMA alignment bullish (above 20/50/200 SMAs). MACD histogram positive (1.12), confirming momentum. OFD pattern: -MTL (Decline).

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_10 | 0.36% (CS: 39) | Neutral |
| RSI_14 | 62.4 | Neutral |
| MACD Histogram | 1.12 | Bullish |
| vs SMA20 | 1.111x | Above |
| vs SMA50 | 1.085x | Above |
| vs SMA200 | 1.088x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $65.90
- **Stop Loss:** $60.90 (7.6% risk)
- **Target:** $70.90 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 200
- **Position Value:** $13,180.00
- **Portfolio %:** 13.18%
- **Risk Dollars:** $1,000.00
- **Risk Per Trade:** 1.00%
- **Modifiers:** L1 100% | L2 100% | Combined 1.00x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | NEUTRAL (Zone E) | 1.00x |

*NORMAL regime with balanced risk positioning. VIX remains calm at 16.48 while breadth shows modest improvement to 52%, indicating neither euphoria nor distress. Mixed sectoral themes from energy weakness to AI expansion suggest stock-picking environment rather than broad directional moves.*

### Earnings

**Next:** 2026-02-05 (Est: $0.38)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.33 | $0.35 | +4.9% |
| 2025Q2 | $0.24 | $0.27 | +13.2% |
| 2025Q1 | $0.10 | $0.11 | +5.3% |
| 2024Q4 | $0.28 | $0.20 | -28.2% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_10*